Bodal Chemicals Ltd
Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]
- Market Cap ₹ 861 Cr.
- Current Price ₹ 68.4
- High / Low ₹ 101 / 65.8
- Stock P/E 117
- Book Value ₹ 90.1
- Dividend Yield 0.00 %
- ROCE 2.80 %
- ROE 0.13 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.76 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.10% over past five years.
- Company has a low return on equity of 4.64% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 3.97% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Dyes And Pigments
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
524 | 960 | 1,043 | 907 | 1,182 | 1,121 | 1,379 | 1,224 | 1,130 | 2,011 | 1,555 | 1,386 | 1,576 | |
503 | 770 | 859 | 758 | 961 | 924 | 1,146 | 1,091 | 1,047 | 1,787 | 1,434 | 1,279 | 1,444 | |
Operating Profit | 21 | 189 | 184 | 150 | 221 | 197 | 233 | 133 | 83 | 224 | 121 | 108 | 132 |
OPM % | 4% | 20% | 18% | 17% | 19% | 18% | 17% | 11% | 7% | 11% | 8% | 8% | 8% |
4 | -70 | 5 | 20 | 15 | 12 | 15 | 14 | 18 | 8 | 8 | 15 | 12 | |
Interest | 39 | 47 | 27 | 12 | 7 | 5 | 7 | 14 | 9 | 21 | 34 | 52 | 68 |
Depreciation | 16 | 25 | 22 | 26 | 26 | 11 | 18 | 26 | 28 | 46 | 52 | 60 | 65 |
Profit before tax | -31 | 47 | 139 | 132 | 203 | 193 | 222 | 106 | 64 | 165 | 43 | 12 | 11 |
Tax % | -32% | 35% | 34% | 34% | 35% | 34% | 35% | 15% | 24% | 25% | 27% | 35% | |
-21 | 31 | 92 | 87 | 133 | 128 | 144 | 90 | 48 | 124 | 31 | 8 | 7 | |
EPS in Rs | -1.94 | 2.81 | 8.43 | 7.94 | 12.18 | 10.44 | 11.79 | 7.37 | 3.95 | 10.15 | 2.48 | 0.61 | 0.59 |
Dividend Payout % | 0% | 0% | 0% | 8% | 7% | 8% | 7% | 11% | 20% | 8% | 4% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 0% |
3 Years: | 7% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | -33% |
5 Years: | -60% |
3 Years: | -69% |
TTM: | 29% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 4% |
3 Years: | -15% |
1 Year: | -16% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 6% |
3 Years: | 5% |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 22 | 22 | 22 | 22 | 22 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | 25 |
Reserves | 16 | 47 | 139 | 218 | 341 | 678 | 811 | 912 | 968 | 1,078 | 1,101 | 1,108 | 1,109 |
359 | 397 | 234 | 143 | 142 | 148 | 135 | 238 | 436 | 640 | 755 | 903 | 836 | |
75 | 132 | 145 | 132 | 187 | 191 | 265 | 249 | 279 | 384 | 281 | 300 | 308 | |
Total Liabilities | 472 | 597 | 539 | 514 | 692 | 1,041 | 1,235 | 1,424 | 1,708 | 2,127 | 2,163 | 2,336 | 2,278 |
265 | 168 | 190 | 184 | 196 | 412 | 529 | 613 | 760 | 804 | 955 | 1,302 | 1,284 | |
CWIP | 0 | 8 | 3 | 0 | 9 | 14 | 20 | 1 | 4 | 70 | 193 | 68 | 69 |
Investments | 2 | 2 | 3 | 3 | 21 | 24 | 20 | 41 | 44 | 99 | 100 | 113 | 101 |
205 | 419 | 343 | 326 | 465 | 591 | 666 | 770 | 899 | 1,155 | 914 | 852 | 824 | |
Total Assets | 472 | 597 | 539 | 514 | 692 | 1,041 | 1,235 | 1,424 | 1,708 | 2,127 | 2,163 | 2,336 | 2,278 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
14 | 49 | 198 | 133 | 112 | 22 | 210 | 65 | -22 | 30 | 246 | 191 | |
-5 | -21 | -35 | -24 | -100 | -216 | -175 | -146 | -171 | -194 | -315 | -266 | |
-10 | -27 | -162 | -109 | -9 | 191 | -29 | 86 | 186 | 162 | 69 | 88 | |
Net Cash Flow | -1 | 1 | 0 | -1 | 3 | -3 | 6 | 6 | -6 | -2 | 1 | 14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 62 | 86 | 69 | 67 | 56 | 89 | 77 | 111 | 128 | 98 | 95 | 99 |
Inventory Days | 61 | 72 | 43 | 56 | 57 | 58 | 77 | 90 | 126 | 141 | 113 | 128 |
Days Payable | 67 | 66 | 62 | 67 | 75 | 77 | 80 | 92 | 101 | 83 | 72 | 101 |
Cash Conversion Cycle | 55 | 92 | 50 | 56 | 39 | 70 | 74 | 109 | 152 | 155 | 136 | 126 |
Working Capital Days | 72 | 89 | 66 | 75 | 62 | 113 | 81 | 117 | 158 | 129 | 135 | 132 |
ROCE % | 2% | 39% | 39% | 35% | 46% | 29% | 25% | 11% | 6% | 11% | 4% | 3% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 Nov - Transcript of Q2 H1 FY25 earnings call submitted.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Bodal Chemicals Limited herewith submit Copies of News paper publication
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14 Nov - Audio recording of investor call on financial results.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
14 Nov - Bodal Chemicals Limited herewith submit Investor presentation
-
Board Meeting Outcome for Outcome Of Board Meeting
14 Nov - Approved standalone and consolidated financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020TranscriptNotesPPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Mar 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019Transcript PPT
-
May 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Mar 2019TranscriptNotesPPT
-
Mar 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Oct 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Jun 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Dec 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Mar 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Nov 2016Transcript PPT
-
Aug 2016TranscriptNotesPPT
-
Jun 2016TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
Product Portfolio
The company has 200+ products in the segments of Basic Chemicals, Dye Intermediates, Dyestuffs & Chlor Alkali. The company recently added Benzene Derivatives to its product portfolio. The users of these chemicals are Textiles, Leather, Paper, Water Treatment, Home Care, Pharma & Agrochemical industries. [1]